{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:17:07Z","timestamp":1790716627947,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.radonc.2026.111718","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:10:16Z","timestamp":1785856216000},"page":"111718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inequitable access to proton beam therapy in Europe: Efficiency, equity, and strategic infrastructure planning to 2030"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0846-8906","authenticated-orcid":false,"given":"Dominik","family":"Wawrzuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Klejdysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"P\u0119dziwiatr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5950-8501","authenticated-orcid":false,"given":"Marzanna","family":"Chojnacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111718_b0005","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1016\/S1470-2045(23)00184-5","article-title":"Global democratisation of proton radiotherapy","volume":"24","author":"Yan","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111718_b0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111718_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctro.2023.100670","article-title":"Patients\u2019 needs in proton therapy: A survey among ten European facilities","volume":"43","author":"Mazzola","year":"2023","journal-title":"Clinical Translational Radiation Oncology"},{"key":"10.1016\/j.radonc.2026.111718_b0020","article-title":"ACR-ARS practice parameter for the performance of proton beam therapy. International journal of particle","volume":"13","author":"Frank","year":"2024","journal-title":"Therapy"},{"key":"10.1016\/j.radonc.2026.111718_b0025","doi-asserted-by":"crossref","unstructured":"Das IJ, Moskvin VP, Zhao Q, Cheng C-W, Johnstone PA. Proton Therapy Facility Planning From a Clinical and Operational Model. Technol Cancer Res Treat SAGE Publications Inc; 2015 Oct 1;14(5):635\u2013641. doi: 10.7785\/tcrt.2012.500444.","DOI":"10.7785\/tcrt.2012.500444"},{"key":"10.1016\/j.radonc.2026.111718_b0030","unstructured":"Cancer Tomorrow. Available from: https:\/\/gco.iarc.who.int\/today\/ [accessed Jan 9, 2026]."},{"key":"10.1016\/j.radonc.2026.111718_b0035","unstructured":"Home - Particle Therapy Co-Operative Group (PTCOG). 2024. Available from: https:\/\/ptcog.online\/ [accessed Jan 17, 2026]."},{"key":"10.1016\/j.radonc.2026.111718_b0040","unstructured":"PTCOG - Start-Page. Available from: https:\/\/www.ptcog.site\/ [accessed Jan 17, 2026]."},{"key":"10.1016\/j.radonc.2026.111718_b0045","unstructured":"GADM. Available from: https:\/\/gadm.org\/index.html [accessed Jan 8, 2026]."},{"key":"10.1016\/j.radonc.2026.111718_b0050","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2017.4","article-title":"WorldPop, open data for spatial demography","volume":"4","author":"Tatem","year":"2017","journal-title":"Sci Data"},{"key":"10.1016\/j.radonc.2026.111718_b0055","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.healthplace.2009.06.002","article-title":"An enhanced two-step floating catchment area (E2SFCA) method for measuring spatial accessibility to primary care physicians","volume":"15","author":"Luo","year":"2009","journal-title":"Health Place"},{"key":"10.1016\/j.radonc.2026.111718_b0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2019.01.007","article-title":"Increased distance from a treating proton center is associated with diminished ability to follow patients enrolled on a multicenter radiation oncology registry","volume":"134","author":"Lawell","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111718_b0065","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.healthpol.2022.10.011","article-title":"Cross-border healthcare collaborations in Europe (2007\u20132017): Moving towards a European Health Union?","volume":"126","author":"Schmidt","year":"2022","journal-title":"Health Policy"},{"key":"10.1016\/j.radonc.2026.111718_b0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.radonc.2021.12.004","article-title":"Current practice in proton therapy delivery in adult cancer patients across Europe","volume":"167","author":"Tambas","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111718_b0075","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J Clinicians"},{"key":"10.1016\/j.radonc.2026.111718_b0080","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2015.04.018","article-title":"The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis","volume":"116","author":"Borras","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111718_b0085","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20211175","article-title":"Estimating the percentage of patients who might benefit from proton beam therapy instead of X-ray radiotherapy","volume":"95","author":"Burnet","year":"2022","journal-title":"BJR"},{"key":"10.1016\/j.radonc.2026.111718_b0090","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/02841860500361049","article-title":"Number of patients potentially eligible for proton therapy","volume":"44","author":"Glimelius","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2026.111718_b0095","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1200\/OP.24.00132","article-title":"Proton therapy: Current status and controversies","volume":"20","author":"Press","year":"2024","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.radonc.2026.111718_b0100","unstructured":"Programme for the implementation of proton therapy in the Spanish public health system. Fundaci\u00f3n Amancio Ortega. Available from: http:\/\/www.faortega.org\/en\/projects\/programme-proton-therapy\/ [accessed June 7, 2026]."},{"key":"10.1016\/j.radonc.2026.111718_b0105","article-title":"Private cancer provider collapses despite drive to tackle NHS backlog","volume":"6","author":"Wise","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.radonc.2026.111718_b0110","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/cncr.29882","article-title":"A systematic review of the cost and cost\u2010effectiveness studies of proton radiotherapy","volume":"122","author":"Verma","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2026.111718_b0115","doi-asserted-by":"crossref","first-page":"e1945","DOI":"10.1016\/S2214-109X(24)00355-3","article-title":"Global radiotherapy demands and corresponding radiotherapy-professional workforce requirements in 2022 and predicted to 2050: A population-based study","volume":"12","author":"Zhu","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.radonc.2026.111718_b0120","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ijrobp.2023.05.012","article-title":"A novel ultrahigh-dose-rate proton therapy technology: spot-scanning proton arc therapy + FLASH (SPLASH)","volume":"117","author":"Liu","year":"2023","journal-title":"Int J Radiation Oncology*Biology*Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026005578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026005578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:36:28Z","timestamp":1790714188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026005578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"alternative-id":["S0167814026005578"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111718","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inequitable access to proton beam therapy in Europe: Efficiency, equity, and strategic infrastructure planning to 2030","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111718"}}